Authors: SCOTT CB SCARANTINO C URTASUN R MOVSAS B JONES CU SIMPSON JR FISCHBACH AJ CURRAN WJ

Citation: Cb. Scott et al., VALIDATION AND PREDICTIVE POWER OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG) RECURSIVE PARTITIONING ANALYSIS CLASSES FOR MALIGNANT GLIOMA PATIENTS - A REPORT USING RTOG-90-06, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 51-55

Authors: WOOD L PALMER M HEWITT J URTASUN R BRUERA E RAPP E THAELL JF

Citation: L. Wood et al., RESULTS OF A PHASE-III, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MEGESTROL-ACETATE MODULATION OF P-GLYCOPROTEIN-MEDIATED DRUG-RESISTANCE IN THE FIRST LINE MANAGEMENT OF SMALL-CELL LUNG-CARCINOMA, British Journal of Cancer, 77(4), 1998, pp. 627-631

Authors: SCOTT CB CHOUCAIR AK URTASUN R NELSON D COIA L CURRAN WJ

Citation: Cb. Scott et al., THE INFLUENCE OF COMPLIANCE ON THE INTERPRETATION OF RESULTS FROM THERADIATION-THERAPY-ONCOLOGY-GROUP STUDY-91-14, Quality of life research, 6(5), 1997, pp. 30-30

Authors: PRADOS M SCOTT C PHILLIPS T DAVIS R SANDLER H BUCKNER J CURRAN W SCHULTZ C URTASUN R

Citation: M. Prados et al., PHASE-III RANDOMIZED STUDY OF RADIOTHERAPY PLUS PCV WITH OR WITHOUT BUDR FOR THE TREATMENT OF ANAPLASTIC ASTROCYTOMA RTOG-9404 INTERIM-REPORT, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 138-138

Authors: CHOUCAIR AK SCOTT C URTASUN R NELSON D MOUSAS B CURRAN W

Citation: Ak. Choucair et al., QUALITY-OF-LIFE AND NEUROPSYCHOLOGICAL EVALUATION FOR PATIENTS WITH MALIGNANT ASTROCYTOMAS - RTOG-91-14, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 9-20

Authors: FULTON D URTASUN R FORSYTH P

Citation: D. Fulton et al., PHASE-II STUDY OF PROLONGED ORAL-THERAPY WITH ETOPOSIDE (VP16) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA, Journal of neuro-oncology, 27(2), 1996, pp. 149-155